Download the TCR-based Therapies Summit Agenda



A new wave of cell immunotherapy may be set to dominate solid tumor indications as TCR-based therapies are charged to invade the hostile microenvironment and tackle tumor indications.

This is your opportunity to gain the know-how across cell immunotherapy with in-depth discussion and insights from pioneers of this exciting new field.

Gain exclusive insights and network with industry leaders at the only TCR-Based Therapies Summit designed to optimize your TCR approach, enhance target selection & accelerate your therapy into the clinic, bringing life-saving therapy to patients who need it the most.


Download the Event Guide to discover:

  • Never-before seen data from novel companies
  • Collaboration with experts in 2 deep-dive workshop sessions on TCR preclinical development & Manufacturing and Logistics
  • 2 open panel discussions with industry leaders

And much more!

Top Speakers Include:

Dolores Schendel



Robert Hofmeister

Chief Scientific Officer


Cheng Liu

Chief Executive Officer

Eureka Therapeutics

Gavin MacBeath

Chief Scientific Officer

TScan Therapeutics

Elisa Kieback



David Scheinberg

Chairman, Molecular Pharmacology

Memorial Sloan Kettering Cancer Center

Gang Zeng

Chief Executive Officer

T-Cure Biosciences Inc.